In various malignant tumors, FAP is overexpressed and has been demonstrated to participate in tumor growth and progression; therefore, efforts in the clinical translation of FAP have been made, including imaging biomarkers, prognostic value and FAP-targeted therapies [8]. Here, FAP is linked to neoplasm.